“Design of a phase 2 first-in-ADPKD clinical trial of the Sodium/Glucose Cotransporter-2 inhibitor (SGLT2i) empagliflozin”
4 December 2023
Presented by Stephen Seliger, M.S., M.D.
University of Maryland School of Medicine
PKD RRC funding is provided by the National Institute of Diabetes and Digestive and Kidney Diseases